Learn how dengue and Zika RVPs enabled clinical progression of Takeda’s Zika and dengue vaccines
Read the case study.
Learn how SARS-CoV-2 RVPs enabled Immunome to test their antibody cocktail and progress their therapeutic into the clinic
Read the case study.
SARS-CoV-2 RVPs and live virus show similar neutralization titers
Read the case study.
Learn how RVPs can be used for sera screening and immunogenicity assays
Read the case study.